U.S. Contraceptives Drugs & Devices Market Analysis-2020


Posted August 5, 2020 by SANJAYCMI

U.S. Contraceptives Drugs And Devices Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

 
U.S. Contraceptives Drugs and Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024

As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that the unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the U.S. that contraceptive manufacturers can address. Moreover, with a no-cost coverage insurance policy for sterilization, growth for U.S. contraceptive drugs and devices market is limited.

Statistics revealed by the United Nations in 2015, mentions that sterilization is a dominant contraceptive method in regions such as North America. Intra-uterine devices (IUDs), vaginal rings, injectables, implants, combined oral contraceptives, and patches are some of the advanced contraceptive methods available in the market. Therefore, various smart strategies adopted by companies marketing contraceptive drugs and devices in the U.S such as promotion through salesforce, social media promotion, awareness campaigns, and sampling is expected to propel the market growth. Moreover, the rising introduction of new male contraceptive products with a high success rate is further projected to shape the course of growth of the U.S. contraceptive drugs and devices market in the near future.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/us-contraceptives-drugs-and-devices-market-368

The global U.S. contraceptive drugs and devices market was valued at US$ 6,785.9 million in 2016 and is expected to expand at a CAGR of 5.6% during the forecast period (2016 – 2024)

Oral pills resulting in volatility in the U.S. contraceptive drugs and devices market

Private companies have a high interest in selling contraceptive pills as they generate continuous revenues for them compared to one-time long-acting contraceptive methods. Furthermore, patent expiration is projected to lead to a barrage of generics entering into the market, further reducing the overall average cost of drugs and in turn market revenue. Global generic pharmaceutical companies such as Teva Pharmaceuticals, Lupin Laboratories, and Cipla Limited are at a pace to launch their generic versions. Emergency contraceptive pills are among the most popular category of pills due to the extensive promotion activities of these products.

Favorable reimbursement scenario and increasing adoption of contraceptives among the low and middle-income population is fostering the market growth

Long-acting reversible contraceptives (LARC) are given complete insurance coverage by the U.S. Affordable Care Act. However, oral pills that generate sustainable revenue are of interest to market players. Furthermore, the State announced insurance coverage of health and reproductive products to continue without any co-pays, co-insurance or deductibles.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/368

In addition to this, the new policy would also cover all medically essential abortion services for the U.S. population. This is a much-anticipated relief for the general population in the U.S., where around 45% of all pregnancies reported are unintended (CDC, 2009-2013 study data).

Insurance coverage for devices also varies from state to state in the U.S. as few states have low Medicaid reimbursement rates than the cost of the device, while few states offer reimbursement only to those women who have been prescribed such devices. For instance, in California, dispensing of injectable contraceptives is only allowed by clinics, while Alabama, Idaho, and South California do not cover emergency contraceptive pills as part of the Medicaid programs in their respective states. Many such limitations in Medicaid coverage creates a disparity in demand for certain contraceptives across regions in the U.S. Rising efforts to standardize the rule all over the country is projected to benefit the population at large and the overall U.S. contraceptive drugs and devices market.

Shifting Preference of user for modern contraceptive methods

A higher success rate and favorable reimbursement policies are encouraging women to opt for these methods over contraceptive pills. Moreover, increasing consumer awareness and rising accessibility to modern contraceptives methods is expected to increase during the forecast period. As per the United Nation’s 2015 report, 9 out of 10 married or in-union women opt for modern contraceptive methods. Furthermore, gynecologists and sexologists are recommending the use of long-acting reversible contraceptives for couples who do not plan to have a child in near future, owing to their high affectivity compared to conventional contraceptives such as oral hormonal pills.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/368

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags us contraceptives drugs and devices market , us contraceptives drugs and devices market analysis , us contraceptives drugs and devices market outlook
Last Updated August 5, 2020